Wegovy may pose greater sudden vision loss risk than other weight-loss injections
Wegovy tied to higher risk of sudden vision loss than Ozempic, analysis suggests
Wegovy, the blockbuster weight-loss drug that contains semaglutide, may carry the highest risk of sudden vision loss among semaglutide medicines, according to a new analysis of U.S. safety reports published in the British Journal of Ophthalmology. The study linked the injections to ischaemic optic neuropathy — often called an “eye stroke” — and found the odds of the condition were roughly three times higher in men than in women.
Semaglutide is…